Key result
The angiotensin II type 2 receptor (AT2R) regulates tissue and organ development and provides a potential counter-regulatory mechanism against AT1R-mediated actions in renal and cardiovascular systems.
Answers are grounded in this paper and cite their sources.
This review provides insights into the biological role of the AT2R, emphasizing its potential counter-regulatory effects against AT1R-mediated actions in renal and cardiovascular diseases.
Angiotensin II (Ang II) is well-considered to be the principal effector of the renin-angiotensin system (RAS), which binds with strong affinity to the angiotensin II type 1 (AT1R) and type 2 (AT2R) receptor subtype. However, activation of both receptors is likely to stimulate different signalling mechanisms/pathways and produce distinct biological responses. The haemodynamic and non-haemodynamic effects of Ang II, including its ability to regulate blood pressure, maintain water-electrolyte balance and promote vasoconstriction and cellular growth are well-documented to be mediated primarily by the AT1R. However, its biological and functional effects mediated through the AT2R subtype are still poorly understood. Recent studies have emphasized that activation of the AT2R regulates tissue and organ development and provides in certain context a potential counter-regulatory mechanism against AT1R-mediated actions. Thus, this review will focus on providing insights into the biological role of the AT2R, in particular its actions within the renal and cardiovascular system.
No takes yet. Share an insight, caveat, or question.
Chow et al. (2016) conducted a review in Renal and cardiovascular disease. Angiotensin II type 2 receptor (AT2R) was evaluated. The angiotensin II type 2 receptor (AT2R) regulates tissue and organ development and provides a potential counter-regulatory mechanism against AT1R-mediated actions in renal and cardiovascular systems.
Synapse has enriched 10 related papers. Consider them for comparative context: